Clin2
NCT06692296Possibly a fitRecruiting

Balance training with a stabilometric platform for Friedreich's ataxia

Friedreich Ataxia

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests if a special platform that measures balance can help people with Friedreich's ataxia stand more steadily. If you have Friedreich's ataxia, can walk at least 10 metres and stand without support, you may be eligible.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
14 years and older
Study type
Interventional

Who can take part

  • You are 14 years old or older
  • You weigh less than 150 kg (about 330 pounds)
  • You have a genetic diagnosis of Friedreich's ataxia
  • Your walking ability is rated between 1 and 6 on the SARA scale (some problems walking, but not the worst or best)
  • Your ability to stand unsupported is rated between 1 and 3 on the SARA scale (some trouble but can stand alone)
  • You can walk at least 10 metres, even if you use a walker or cane, and you can stand without help

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07778836Recruiting· Phase 3
Study of daily injections for Friedreich's ataxia

This study tests an investigational drug given as a daily injection to see if it can improve walking and balance in people with Friedreich's ataxia.

Tampa, Florida
NCT07731971Not yet recruiting
Using active video games to assess movement in Friedreich ataxia

This study uses fun motion-sensing games (like active video games) to measure movement and coordination in people with Friedreich ataxia. It aims to see if these digital tools can track the disease at home, which might make future monitoring easier.

Exeter
NCT06772870Not yet recruiting· Phase 1
Testing a new medicine in healthy volunteers

This study tests a new medicine called DT-216P2 in healthy people to find a safe dose. It is a first step in developing a treatment for Friedreich ataxia, a genetic condition that affects movement and balance.

Melbourne, Victoria
NCT07805850Recruiting
Balance training for people with multiple sclerosis

This study tests different ways of monitoring balance exercises during a rehabilitation stay to see which is more effective and feasible. It may help improve balance and safety in daily life for people with MS.

Valens, Canton of St. Gallen
NCT05983809Recruiting
Balance and walking rehab using technology for MS

This trial tests a new type of balance and walking training for people with multiple sclerosis. It uses technology to help improve your stability and gait, which may help you move more safely and confidently.

Roma, RM
NCT06641973Not yet recruiting
Balance training for eating disorder recovery

This study tests a balance rehabilitation program for people with eating disorders. It may help improve physical stability and support overall recovery.

Roma, Roma

Hear when a new Friedreich Ataxia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.